TSXV/COV (TSXV/COV)

TSX Venture Exchange: TSXV/COV · CAD

CA$4.47

-0.03 (-0.7%)· Recorded snapshot

Market cap	123.5M
Revenue (ttm)	34.3M
Net income (ttm)	4.4M
EPS (ttm)	CA$0.16
Shares out	27.6M
P/E (trailing)	28.1x
P/E (forward)	23.4x
Dividend	CA$0.15 (3.36%)
Volume	5,935
Beta	0.16

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 34.3M
Net income (ttm): 4.4M
EPS (ttm): CA$0.16
P/E (trailing): 28.1x
P/E (forward): 23.4x
Market cap: 123.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E23.4

P25 n/aP50 n/aP75 n/a

Trailing P/E28.1

P25 n/aP50 n/aP75 n/a

ROE14.3

P25 n/aP50 n/aP75 n/a

ROIC7.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/COV indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

CAD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-16
Employees	37
Enterprise value	CAD 105.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	2004
Industry	Medical Instruments & Supplies
Is primary listing	Yes
ISIN number	CA22282D3022
Last earnings date	2026-08-27
Last refreshed	2026-10-29
Last stock split date	2013-07-16
Last stock split type	Reverse
Market cap	CAD 123.5M
Next earnings date	2026-12-16
Price	CAD 4.47
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	tsxv/COV
Website	https://covalon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	27.88x
Average P/E ratio (3Y)	27.29x
Earnings yield	3.56%
EV/Earnings	24.29x
EV/EBIT	27.01x
EV/EBITDA	23.9x
EV/FCF	19.22x
EV/Sales	3.1x
FCF / EV yield	5.2%
FCF yield	4.46%
Forward P/E	23.38x
Graham number	2.02302
Graham upside	-55.04%
P/(FCF - SBC) ratio	23.7x
P/(OCF - SBC) ratio	19.18x
P/B ratio	3.94x
P/E ratio	28.07x
P/FCF ratio	22.41x
P/OCF ratio	18.33x
P/S ratio	3.62x
Price / tangible book value	4.11x
Price/EBITDA ratio	30.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.49%
EBITDA margin	11.8%
FCF margin	16.15%
Gross margin	59.87%
Operating margin	11.49%
Pretax margin	12.78%
Profit margin	12.78%
Profit per employee	CAD 118,595
Profitable quarters	10
Profitable years	2
Revenue per employee	CAD 928,333
ROA	6.87%
ROA (5Y)	-3.39%
ROCE	11.99%
ROE	14.33%
ROE (5Y)	-6.46%
ROIC	7.68%
SBC / revenue	0.88%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	84.93%
EPS growth (Q)	4,225.26%
EPS growth (QoQ)	152.58%
EPS growth quarters	2
EPS growth years	0
FCF growth	22.34%
FCF growth (Q)	45.3%
FCF growth 5Y	44.51%
Gross profit growth	11.95%
Gross profit growth (Q)	73.3%
Gross profit growth 3Y	17.17%
Gross profit growth 5Y	102.36%
Net income growth	89.74%
Net income growth (Q)	4,253.37%
Net income growth (QoQ)	157.06%
Net income growth quarters	2
Net income growth years	0
OCF growth	33.46%
OCF growth (Q)	31.96%
OCF growth 5Y	49.4%
Operating income growth	80.79%
Revenue growth	4.11%
Revenue growth (Q)	19.93%
Revenue growth (QoQ)	15.06%
Revenue growth 10Y	15.78%
Revenue growth 3Y	11.04%
Revenue growth 5Y	39.17%
Revenue growth quarters	2
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -1.2M
Depreciation and amortization	CAD 106,902
EBIT	CAD 3.9M
EBITDA	CAD 4.1M
EPS	CAD 0.16
FCF per share	CAD 0.20
Financing cash flow	CAD -4.8M
Free cash flow	CAD 5.5M
Free cash flow minus SBC	CAD 5.2M
Gross profit	CAD 20.6M
Investing cash flow	CAD -1.4M
Net borrowing	CAD -755,710
Net cash flow	CAD 1.3M
Net income	CAD 4.4M
Operating cash flow minus SBC	CAD 6.5M
Operating income	CAD 3.9M
Revenue	CAD 34.3M
Stock-based compensation	CAD 300,950

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.64
Book value per share	CAD 1.14
Debt / EBITDA	0.38
Debt / equity	0.05
Debt / FCF	0.3
Long-term assets	CAD 5.1M
Long-term liabilities	CAD 1.3M
Net cash (debt)	CAD 17.7M
Net cash / market cap	14.24%
Net cash growth	5.27%
Net debt / EBITDA	-4.37
Net debt / equity	-0.56
Net debt / FCF	-3.19
Piotroski F-Score	6
Property, plant and equipment	CAD 3.8M
Shareholders' equity	CAD 31.5M
Tangible book value	CAD 30.3M
Tangible book value per share	CAD 1.10
Total assets	CAD 36.6M
Total cash	CAD 19.4M
Total debt	CAD 1.7M
Total liabilities	CAD 5M
WACC	5.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.96
Current assets	CAD 31.5M
Current liabilities	CAD 3.7M
Current ratio	8.56
Inventory turnover	1.82
Net working capital	CAD 8.7M
Quick ratio	6.51
Working capital	CAD 27.8M
Working capital turnover	1.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.25%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2025-11-18
Dividend payment years	1
Dividend per share	CAD 0.15
Dividend yield	3.36%
Ex-dividend date	2025-11-04
FCF payout ratio	74.7%
Last dividend	CAD 0.15
Payout ratio	94.41%
Shareholder yield	2.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	152.54%
10Y return CAGR	10.47%
10Y total return	170.58%
150-day SMA	CAD 2.59
15Y price change	198%
15Y return CAGR	8.05%
15Y total return	219.29%
1D price change	-0.67%
1M price change	-1.97%
1M total return	-1.97%
1W price change	7.19%
1W total return	7.19%
1Y price change	96.05%
1Y return CAGR	110.16%
1Y total return	110.06%
20-day SMA	CAD 4.11
200-day SMA	CAD 2.37
20Y price change	-4.89%
20Y return CAGR	0.09%
20Y total return	1.9%
3M price change	100.45%
3M total return	100.45%
3Y price change	313.89%
3Y return CAGR	64.27%
3Y total return	343.45%
50-day SMA	CAD 3.63
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 4.59
52-week high date	2026-09-29
52-week low	CAD 1.55
52-week low date	2026-02-10
5Y price change	78.8%
5Y return CAGR	13.89%
5Y total return	91.57%
6M price change	136.51%
6M total return	136.51%
All-time high	CAD 38.50
All-time high date	2007-11-06
All-time low	CAD 0.13
All-time low date	2013-07-29
Average true range (ATR)	CAD 0.21
Average volume	19.2K
Beta (1Y)	0.45
Beta (2Y)	0.22
Beta (5Y)	0.16
Change from 52-week high	-2.61%
Change from 52-week low	188.39%
Change from all-time high	-88.39%
Change from all-time low	3,338.46%
Change from open	-0.67%
Day's gap	0%
Dollar volume	CAD 26,529
High price	CAD 4.50
Low price	CAD 4.47
Monthly RSI	75.58
Open price	CAD 4.50
Position in 52-week range	0%
Previous close	CAD 4.50
Price vs 150-day SMA	72.72%
Price vs 20-day SMA	8.71%
Price vs 200-day SMA	88.61%
Price vs 50-day SMA	23.14%
Relative volume	0.31
RSI	61.54
Sharpe ratio	1.61
Sharpe ratio (3Y)	0.69
Sharpe ratio (5Y)	0.65
Sortino ratio	2.98
Sortino ratio (3Y)	1.25
Sortino ratio (5Y)	1.15
Volume	5.9K
Weekly RSI	83.39
YTD price change	156.9%
YTD total return	156.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14.9M
Shares change (QoQ)	0.38%
Shares change (YoY)	1.25%
Shares held by insiders	32.57%
Shares held by institutions	3.62%
Shares outstanding	27.6M

Deeper analysis on TSXV/COV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/COV report

Is a complete TSXV/COV research report available?

No complete published report is available for tsxv/COV (TSXV/COV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/COV (TSXV/COV)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/COV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/COV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/COV

Frequently asked questions